Patents and R and D as real options

Economic Notes

Volumn 33, Issue 1, 2004, Pages 23-54

  Schwartz, Eduardo S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INNOVATION; PHARMACEUTICAL INDUSTRY; RESEARCH AND DEVELOPMENT; TECHNOLOGICAL DEVELOPMENT;

EID: 2942605728     PISSN: 03915026     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0391-5026.2004.00124.x     Document Type: Article

References (36)

1. J. B. BERK - R. C. GREEN - V. NAIK (2003), "Valuation and Return Dynamics of New Ventures", Review of Financial Studies, forthcoming.
2. N. BLOOM - J. VAN REENEN (2000), "Real Options, Patents, Productivity and Market Value: Evidence from a Panel of British firms", IFS Working Paper.
3. M. J. BRENNAN - E. S. SCHWARTZ (1985), "Evaluating Natural Resource Investments", Journal of Business, 58, pp. 135-57.
4. R. E. CAVES - M. D. WHINSTON - M. A. HURWITZ (1991), "Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry", Brookings Papers: Microeconomics, pp. 1-79.
5. P. D. CHILDS - A. J. TRIANTIS (1999), "Dynamic R&D Investment Policies", Management Science, 45(10), pp. 1359-1377.
6. I. COCKBURN - R. HENDERSON (1994), "Racing to Invest? The Dynamics of Competition in Ethical Drug Discovery", Journal of Economic and Management Strategy, 3(3), pp. 481-519.
7. J. A. DiMASI - R. W. HANSEN - H. G. GRABOWSKI - L. LASAGNA (1991), "Cost of Innovation in the Pharmaceutical Industry", Journal of Health Economics, 10, pp. 107-42.
8. J. A. DIMASI - H. G. GRABOWSKI - J. VERNON (1995a), "R&D Costs, Innovative Output and Firm Size in the Pharmaceutical Industry", International Journal of the Economics of Business, 2(2 ), pp. 201-19.
9. J. A. DIMASI - R. W. HANSEN - H. G. GRABOWSKI - L. LASAGNA (1995b), "Research and Development Costs for New Drugs by Therapeutic Category: A Study of the US Pharmaceutical Industry", Pharmaco Economics, 7(2), pp. 152-69.
10. A. K. DIXIT - R. S. PINDYCK (1994), Investment under Uncertainty, Princeton, NY: Princeton University Press.
11. N. GALLINI - S. SCOTCHMER (2002), "Intellectual Property: When is it the Best Incentive System?", in A. B. Jaffe, J. Lerner and S. Stern (eds), Innovation Policy and the Economy, Vol. 2, Cambridge MA: MIT Press, pp. 57-78.
12. H. G. GRABOWSKI - J. M. VERNON (1990), "A New Look at the Returns and Risks to Pharmaceutical R&D", Management Science, 36(7), pp. 804-21.
13. H. G. GRABOWSKI - J. M. VERNON (1992), "Brand Loyalty, Entry, and Price Competition in Pharmaceutical after the 1984 Drug Act", Journal of Law and Economics, 35, pp. 331-50.
14. H. G. GRABOWSKI - J. M. VERNON (1994), "Returns on R&D on New Drug Introductions in the 1980s", Journal of Health Economics, 13, pp. 383-406.
15. R. HENDERSON - I. COCKBURN (1996a), "Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery", Rand Journal of Economics, 27(1), pp. 32-59.
16. R. HENDERSON - I. COCKBURN (1996b), "The Determinants of Research Productivity in Ethical Drug Discovery", in Robert B. Helms, (ed.), Competitive Strategies in the Pharmaceutical Industry, Washington, DC: AEI Press, The American Enterprise Institute Conference Volume.
17. K. I. KAITIN - J. A. DIMASI (2000), "Measuring the Pace of New Drug Development in the User Fee Era", Drug Information Journal, 34, pp. 673-80.
18. J. O. LANJOUW - M. SCHANKERMAN (2001), "Characteristics of Patent Litigation: A Window on Competition", Rand Journal of Economics, 32(1), pp. 129-51.
19. F. A. LONGSTAFF - E. S. SCHWARTZ (2001), "Valuing American Options by Simulation: A Simple Least-Square Approach", Review of Financial Studies, 14(1), pp. 113-47.
20. M. S. MARKS (1996), "The Impact of the Patent Term Provisions of the 1994 Uruguay Round Agreement Act on the Drug Price Competition and Patent Term Restoration Act", Food and Drug Law Journal, 51, pp. 445-70.
21. R. C. MERTON (1973), "An Intertemporal Capital Asset Pricing Model", Econometrica, 41, pp. 867-87.
22. K. R. MILTERSEN - E. S. SCHWARTZ (2002), "R&D Investments with Competitive Interactions", UCLA Working Paper.
23. S. C. MYERS - C. D. HOWE (1997), "A Life-Cycle Financial Model of Pharmaceutical R&D", MIT Working Paper.
24. J. L. PADDOCK - D. R. SIEGEL - J. L. SMITH (1988), "Option Valuation of Claims on Real Assets: The Case of Offshore Petroleum Leases", Quarterly Journal of Economics, 103, pp. 479-508.
25. A. PAKES (1985), "On Patents, R&D, and the Stock Market Rate of Return", Journal of Political Economy, 93(2), pp. 390-409.
26. A. PAKES (1986), "Patents as Options: Some Estimates of the Value of Holding European Patent Stocks", Econometrica, 54(4), pp. 755-84.
27. J. R. PARRY - L. C. ROSE - D. G. SMITH (1999), "Efficient Funding of Biotechnology Firms - A Pecking Order Approach", Working Paper, Massay University, New Zealand.
28. R. S. PINDYCK (1993), "Investments of Uncertain Cost", Journal of Financial Economics, 34, pp. 53-76.
29. J. F. REINGANUM (1989), "The Timing of Innovation: Research, Development and Diffusion", in R. Schmalensee and R. Willig (eds), Handbook of Industrial Organization, Volume 1, Amsterdam: North Holland, pp. 849-908.
30. M. SAKAKIBARA - L. BRANSTETTER, (2001), "Do Stronger Patents Induce More Innovation? Evidence from the 1988 Japanese Patent Law Reforms", Rand Journal of Economics, 32(1), pp. 77-100.
31. M. SCHANKERMAN - S. SCOTCHMER (2001), "Damages and Injunctions in Protecting Intellectual Property", Rand Journal of Economics, 32(1), pp. 199-220.
32. E. S. SCHWARTZ - M. MOON (2000), "Evaluating Research and Development Investments", in M. J. Brennan and L. Trigeorgis (eds), Innovation, Intrastructure and Strategic Options New York: Oxford University Press, pp. 85-106.
33. Rational Pricing of Internet Companies Revisited", The Financial Review, 36, pp. 7-26.
34. E. S. SCHWARTZ - C. ZOZAYA (2001a), "Valuing Investments in Information Technology as Real Options", UCLA Working Paper.
35. E. S. SCHWARTZ - C. ZOZAYA (2001b), "Evaluating Investments in Disruptive Technologies", in Mathematical Finance - Bachelier 2000, Editors H. Geman, D. Madan, S. Pliska and T. Vost, Springer-Verlag, pp. 463-486.
36. L. TRIGEORGIS (1996), Real Options: Managerial Flexibility and Strategy in Resource Allocation, Cambridge, MA: MIT Press.